Page last updated: 2024-08-24

diminazene aceturate and Obesity

diminazene aceturate has been researched along with Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruce, EB; Carter, CS; Kirichenko, N; Morgan, D; Sakarya, Y; Scarpace, PJ; Sumners, C; Toklu, HZ; Tümer, N	1

Other Studies

1 other study(ies) available for diminazene aceturate and Obesity

Article	Year
ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats. Experimental gerontology, 2018, 10-01, Volume: 111 Topics: Adiposity; Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Gene Expression; Male; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred F344; Renin-Angiotensin System	2018

Article

Year

ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats.

Experimental gerontology, 2018, 10-01, Volume: 111

Topics: Adiposity; Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Gene Expression; Male; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred F344; Renin-Angiotensin System

2018